1992-06-24
The cost-effectiveness of cholesterol-lowering therapy with simvastatin in the primary prevention of coronary heart disease in the Netherlands
Publication
Publication
De kosten-effectiviteit van verlaging van het serumcholesterol middels simvastatine in de preventie van coronaire hartziekten
The research presented in this dissertation was conducted to answer the question: how does the cost-effectiveness of therapy with simvastatin compare with that of current cholesterol-lowering therapy and that of other generally accepted medical practices in the Netherlands?
| Additional Metadata | |
|---|---|
| , , , , | |
| The research described in this dissertation was supported by a grant in aid from Merck & Co., Inc., Rahway, New Jersey, U.S.A. | |
| F.F.H. Rutten (Frans) | |
| Erasmus University Rotterdam | |
| hdl.handle.net/1765/38024 | |
| Organisation | Erasmus School of Health Policy & Management (ESHPM) |
|
Martens, L. L. (1992, June 24). The cost-effectiveness of cholesterol-lowering therapy with simvastatin in the primary prevention of coronary heart disease in the Netherlands. Retrieved from http://hdl.handle.net/1765/38024 |
|
| Additional Files | |
|---|---|
| stellingen Martens.pdf , 42kb | |
| 0849_Martens, Leonardus Lambertus.jpg Cover Image , 26kb | |
